Target intelligence / Profile preview

elongin C pseudogene 19 (ELOCP19)

Target
ELOCP19
Molecular classification
Other (Pseudogene)
01

Overview

elongin C pseudogene 19 is classified as a pseudogene, specifically related to the elongin C gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they generally lack coding potential due to mutations such as insertions, deletions, or frame-shifts that prevent proper transcription or translation. ELOCP19 has no known protein product, biological function, or relevance as a therapeutic target, and should not be confused with the canonical elongin C gene (ELOC), which is involved in transcription elongation processes. ELOCP19 is catalogued as a pseudogene in NCBI Gene (GeneID: 100462880), ENSEMBL (ENSG00000241975), and HGNC resources. No evidence supports its involvement in any molecular function, disease mechanism, or drug interaction. It is not a receptor, enzyme, transporter, or regulatory protein; its entry is provided mainly for genomics reference. The active, protein-coding gene "elongin C" (ELOC) is a separate functional entity important in transcription and ubiquitin ligase complexes, but ELOCP19 is not functionally equivalent or relevant in human biology as a protein or molecular drug target. This entry is most useful for distinguishing non-functional pseudogene loci from true druggable or functional protein targets.

Other names
TCEB1P19

Beyond the preview

Go deeper on elongin C pseudogene 19 (ELOCP19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on elongin C pseudogene 19 (ELOCP19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call